N. Kashirskaya

3.1k total citations · 1 hit paper
85 papers, 993 citations indexed

About

N. Kashirskaya is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Surgery. According to data from OpenAlex, N. Kashirskaya has authored 85 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 16 papers in Emergency Medical Services and 11 papers in Surgery. Recurrent topics in N. Kashirskaya's work include Cystic Fibrosis Research Advances (67 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (16 papers). N. Kashirskaya is often cited by papers focused on Cystic Fibrosis Research Advances (67 papers), Neonatal Respiratory Health Research (26 papers) and Tracheal and airway disorders (16 papers). N. Kashirskaya collaborates with scholars based in Russia, France and Italy. N. Kashirskaya's co-authors include À. Munck, Kevin W Southern, Isabelle Sermet‐Gaudelus, Mandy Bryon, Patrick A. Flume, Gerald Ullrich, Sarah Jane Schwarzenberg, Scott C. Bell, Alistair Duff and Alan R Smyth and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

N. Kashirskaya

73 papers receiving 958 citations

Hit Papers

European Cystic Fibrosis Society Standards of Care: Best ... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
    2014 371 citations N. Kashirskaya, À. Munck et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Kashirskaya Russia 14 837 112 101 83 68 85 993
Donatello Salvatore Italy 18 752 0.9× 82 0.7× 72 0.7× 60 0.7× 65 1.0× 58 876
John Massie Australia 7 955 1.1× 92 0.8× 102 1.0× 61 0.7× 71 1.0× 9 1.1k
Tamarah Katz Australia 16 561 0.7× 181 1.6× 61 0.6× 161 1.9× 142 2.1× 34 826
Antônio Fernando Ribeiro Brazil 14 455 0.5× 119 1.1× 84 0.8× 46 0.6× 51 0.8× 47 650
J.E. Dankert-Roelse Netherlands 19 1.1k 1.3× 44 0.4× 104 1.0× 66 0.8× 45 0.7× 43 1.2k
Fabio Majo Italy 14 299 0.4× 147 1.3× 117 1.2× 39 0.5× 120 1.8× 40 568
Oded Breuer Israel 16 428 0.5× 49 0.4× 133 1.3× 27 0.3× 69 1.0× 46 608
Antônio Fernando Ribeiro Brazil 15 358 0.4× 69 0.6× 77 0.8× 24 0.3× 54 0.8× 43 527
Lucas L. Kulczycki United States 15 547 0.7× 134 1.2× 51 0.5× 44 0.5× 102 1.5× 30 793
W. Theodore Bruns United States 10 760 0.9× 40 0.4× 93 0.9× 44 0.5× 23 0.3× 13 968

Countries citing papers authored by N. Kashirskaya

Since Specialization
Citations

This map shows the geographic impact of N. Kashirskaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Kashirskaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Kashirskaya more than expected).

Fields of papers citing papers by N. Kashirskaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Kashirskaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Kashirskaya. The network helps show where N. Kashirskaya may publish in the future.

Co-authorship network of co-authors of N. Kashirskaya

This figure shows the co-authorship network connecting the top 25 collaborators of N. Kashirskaya. A scholar is included among the top collaborators of N. Kashirskaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Kashirskaya. N. Kashirskaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kashirskaya, N., E. Kondratyeva, Т. Б. Бухарова, et al.. (2024). Comprehensive Assessment of CFTR Modulators’ Therapeutic Efficiency for N1303K Variant. International Journal of Molecular Sciences. 25(5). 2770–2770. 3 indexed citations
2.
Munck, À., Kevin W Southern, J. Patrick Murphy, et al.. (2023). Cystic Fibrosis Cases Missed by Newborn Bloodspot Screening—Towards a Consistent Definition and Data Acquisition. International Journal of Neonatal Screening. 9(4). 65–65. 2 indexed citations
3.
Симонова, О. И., et al.. (2023). Characteristics of post COVID-19 condition in children after mild COVID-19. Meditsinskiy sovet = Medical Council. 187–193.
4.
5.
Colombo, Carla, Grant A. Ramm, Anders Lindblad, et al.. (2023). Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators. Journal of Cystic Fibrosis. 22(2). 263–265. 4 indexed citations
6.
Симонова, О. И., et al.. (2022). The features of carbohydrate metabolism in children with cystic fi brosis: a 30-year-long history. Experimental and Clinical Gastroenterology. 93–106.
7.
8.
Colombo, Carla, Gianfranco Alicandro, Mark Oliver, et al.. (2021). Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study. Journal of Cystic Fibrosis. 21(2). 220–226. 21 indexed citations
9.
10.
11.
Роживанов, Р. В., et al.. (2018). ANDROLOGY EXAMINATION OF PATIENTS WITH PANCREATIC-SUFFICIENT AND PANCREATIC-INSUFFICIENT CYSTIC FIBROSIS. Andrology and Genital Surgery. 19(2). 31–39. 1 indexed citations
12.
Петрова, Н.В., N. Kashirskaya, Sergey I. Kutsev, et al.. (2018). Cystic fibrosis phenotype with the complex allele s466x-r1070q in Russian Federation Elena I. Kondrat'eva1. PULMONOLOGIYA. 27(6). 695–703. 2 indexed citations
13.
Shaginyan, I.A., M.Y. Chernukha, E. Kondratyeva, et al.. (2017). 162 Phenotypic and genotypic variability of pathogens of chronic lung infection in cystic fibrosis patients. Journal of Cystic Fibrosis. 16. S107–S108. 1 indexed citations
14.
Sherman, V., et al.. (2017). INFLUENCE OF NEONATAL SCREENING FOR CYSTIC FIBROSIS BY THE EXAMPLE OF PATIENTS OF THE MOSCOW REGION. Meditsinskiy sovet = Medical Council. 124–128. 4 indexed citations
15.
Sherman, V., et al.. (2016). THE CLINICAL AND GENETIC CHARACTERISTICS AND OUTCOMES OF MECONIUM ILEUS IN CYSTIC FIBROSIS. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 61(6). 77–81. 1 indexed citations
16.
Aa, Baranov, et al.. (2015). Contemporary Understanding of Diagnosis and Treatment of Children with Cystic Fibrosi. SHILAP Revista de lepidopterología. 12(5). 589–589. 2 indexed citations
17.
Kashirskaya, N., et al.. (2013). A role of Moscow regional register for management of cystic fibrosis patients. PULMONOLOGIYA. 27–32. 1 indexed citations
18.
Kashirskaya, N., et al.. (2013). HISTORICAL AND MODERN ASPECTS OF CYSTIC FIBROSIS IN RUSSIA. SHILAP Revista de lepidopterología. 10(6). 53–53. 3 indexed citations
19.
Amelina, E., et al.. (2012). Cystic fibrosis and tuberculosis. PULMONOLOGIYA. 34–39. 1 indexed citations
20.
Kashirskaya, N., et al.. (2010). Efficacy and safety of tobramycin and colistin for inhalation in children with cystic fibrosis from Moscow region. Journal of Cystic Fibrosis. 9. S54–S54. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donatello Salvatore Breakdown of academic impact, for papers by John Massie Breakdown of academic impact, for papers by Tamarah Katz Breakdown of academic impact, for papers by Antônio Fernando Ribeiro Breakdown of academic impact, for papers by J.E. Dankert-Roelse Breakdown of academic impact, for papers by Fabio Majo Breakdown of academic impact, for papers by Oded Breuer Breakdown of academic impact, for papers by Antônio Fernando Ribeiro Breakdown of academic impact, for papers by Lucas L. Kulczycki Breakdown of academic impact, for papers by W. Theodore Bruns
Rankless by CCL
2026